Julie Hambleton, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 27,548 shares at $53.01 ($1.5M) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.01 | 13,774 | $730K | 50.0% |
| 2 | $53.01 | 13,774 | $730K | 50.0% |
| Total | $53.01 avg | 27,548 | $1.5M | 100% |
| Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |
| SWTX | SELL | 2023-03-16 | $35K | — | Filing → |